High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.

Authors:
Winkelman JW.

Journal:
Sleep

Publication Year: 2022

DOI:
10.1093/sleep/zsab212

PMCID:
PMC8842153

PMID:
34417810

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Sleep

Abbreviation: Sleep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Automatic sleep spindles identification and classification with multitapers and convolution.
Zapata IA; Wen P; Jones E and 2 more (2024) - Transparency Score: 3/6
English translation of the first study reporting cyclical periods of increased respiration and eye …
Denisova K. (2024) - Transparency Score: 3/6
The interrelationships between sleep regularity, obstructive sleep apnea, and hypertension in a mid…
Sansom K; Reynolds A; Windred D and 7 more (2024) - Transparency Score: 4/6
Association between indoor noise level at night and objective/subjective sleep quality in the older…
Yamagami Y; Obayashi K; Tai Y and 1 more (2023) - Transparency Score: 3/6
Association between insomnia phenotypes and subclinical myocardial injury: the Multi-Ethnic Study o…
Sigurdardottir FD; Bertisch SM; Reid ML and 4 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Statements Financial Disclosures: John W. Winkelman has received research funding from American Regent, Inc.; Merck & Co., Inc.; and the RLS Foundation. He has consulted for Avadel Pharmaceuticals plc; CVS Health; Emalex Biosciences, Inc.; Idorsia Pharmaceuticals Ltd; Noctrix Health, Inc.; and UpToDate, Inc. Nonfinancial Disclosures: None."

Evidence found in paper:

"Funding This study was funded by Arbor Pharmaceuticals, LLC. Data analysis was conducted by Mark Jaros, PhD, Summit Analytical, and funded by Arbor Pharmaceuticals, LLC. Dr Winkelman received no funding for any work related to this manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025